SCHEMBL18871998

SCHEMBL18871998

CC(=O)N1c2ccc(-c3ccc(C(=O)N4CCCC4)cc3)cc2CC[C@@H]1C

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 9/20 0.58
PDK2 Q15119 9/20 0.58
PDK3 Q15120 9/20 0.58
PDK4 Q16654 9/20 0.58
BRD4 O60885 1/20 0.52
HRH3 Q9Y5N1 3/20 0.49
KCNH2 Q12809 2/20 0.49
HTR1A P08908 1/20 0.49
SLC6A4 P31645 1/20 0.49
HRH1 P35367 1/20 0.49
HPGD P15428 3/20 0.46
MAPK1 P28482 1/20 0.46
TSHR P16473 3/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18871849 0.90 HRH3 (0.50) PDK1PDK2PDK3PDK4BRD4
SCHEMBL26071914 0.86 CYP11B1 (0.47) PDK1PDK2PDK3PDK4BRD4
SCHEMBL26071793 0.84 PDK1 (0.54) PDK1PDK2PDK3PDK4BRD4
SCHEMBL14756207 0.84 PDK1 (0.54) PDK1PDK2PDK3PDK4BRD4
SCHEMBL14756232 0.82 PDK1 (0.47) PDK1PDK2PDK3PDK4BRD4
SCHEMBL14756175 0.81 BRD4 (0.56) PDK1PDK2PDK3PDK4BRD4
SCHEMBL14756761 0.81 PDK1 (0.45) PDK1PDK2PDK3PDK4BRD4
SCHEMBL30366353 0.81 PDK1 (0.48) PDK1PDK2PDK3PDK4MAPK1
SCHEMBL26072484 0.81 PDK1 (0.48) PDK1PDK2PDK3PDK4MAPK1
SCHEMBL26071772 0.81 ALDH1A1 (0.45) PDK1PDK2PDK3PDK4BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3168213-B1 TETRAHYDROQUINOLINE DERIVATIVES USEFUL AS BROMODOMAIN INHIBITORS GLAXOSMITHKLINE LLC (US) 2018-08-01 EP disclosed
EP-3168213-A1 TETRAHYDROQUINOLINE DERIVATIVES USEFUL AS BROMODOMAIN INHIBITORS Glaxosmithkline LLC (US) 2017-05-17 EP disclosed